» Articles » PMID: 39731655

Utilizing a Combination of Supplements Comprising Boric Acid, Magnesium, Vitamin D3, and Extra Virgin Olive Oil to Improve Metabolism in Menopausal Ovariectomized Rats

Overview
Date 2024 Dec 28
PMID 39731655
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic syndrome during menopause can lead to diabetes, cardiovascular problems, and increased mortality rates. Hormone replacement therapy is recommended to manage climacteric complications, but it has serious adverse effects. This study, therefore, investigated the potential of supplementing some minerals, vitamins, and natural products like boric acid, magnesium, vitamin D3, and extra virgin olive oil on metabolic status of menopausal ovariectomized rats. Fourty-two female adult rats were randomly assigned to seven groups: a) Sham Control, b) Ovariectomized Control, c) Ovariectomized + Boric acid, d) Ovariectomized + Magnesium, e) Ovariectomized + Vitamin D3, f) Ovariectomized + Extra virgin olive oil, and g) Ovariectomized + Combined treatment groups. Serum inflammatory and oxidative stress markers, serum lipogram pattern, hepatic triglycerides, body weight, fasting blood glucose, serum insulin, leptin, and adiponectin, as well as hepatic insulin signaling cascade, IRS1/pAKT/GLUT4 were measured in each group to assess metabolic function. Results revealed a significant improvement in inflammation, oxidative stress, and metabolic parameters by individual and concomitant treating ovariectomized rats with boric acid, magnesium, vitamin D3, and extra virgin olive oil. Interestingly, the concurrent use of these supplements displayed a better impact than individual use, suggesting their valuable therapeutic potential for managing metabolic syndrome in menopausal women. However, the necessity of all four supplements for optimal therapeutic effects remains unsubstantiated.

References
1.
Crandall C, Mehta J, Manson J . Management of Menopausal Symptoms: A Review. JAMA. 2023; 329(5):405-420. DOI: 10.1001/jama.2022.24140. View

2.
Fahed G, Aoun L, Zerdan M, Allam S, Zerdan M, Bouferraa Y . Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022; 23(2). PMC: 8775991. DOI: 10.3390/ijms23020786. View

3.
Jeong H, Park H . Metabolic Disorders in Menopause. Metabolites. 2022; 12(10). PMC: 9606939. DOI: 10.3390/metabo12100954. View

4.
Raman V, Kose V, Somalwar S, Dwidmuthe K, Rao S . Prevalence of Metabolic Syndrome and Its Association With Menopausal Symptoms in Post-Menopausal Women: A Scoping Review. Cureus. 2023; 15(5):e39069. PMC: 10267665. DOI: 10.7759/cureus.39069. View

5.
Bah S . How feasible is the life expectancy target in the Saudi Arabian vision for 2030?. East Mediterr Health J. 2018; 24(4):401-404. DOI: 10.26719/2018.24.4.401. View